Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update

Transcription

1 Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update

2 Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or reportstore@bioportfolio.com 2

3 Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update Summary Abbott Vascular Inc. (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories is a medical device company that research, develops, manufactures, and markets therapeutic solutions for the treatment of cardiac and vascular diseases. The company offers coronary intervention products including bleedback control valve, coronary dilatation catheters, coronary drug eluting stents, coronary guide wires and others; peripheral intervention products such as peripheral dilatation catheters, peripheral guide wires, peripheral stent systems and others. The company also offers vessel closure products including clip closure, suture-mediated closure and vessel closure accessories and others. It also offers product technology solutions for the customers. Abbott Vascular is headquartered in Santa Clara, California, the US. This report is a source for data, analysis, and actionable intelligence on the company s portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Abbott Vascular Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies 3

4 - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio Additional Details Publisher : Global Data Reference : GDME6037PD Number of Pages : 53 Report Format : PDF Publisher Information : 4

5 Table Of Contents for Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update Table of Contents Table of Contents 2List of Tables 4List of Figures 6Abbott Vascular Inc. Company Snapshot 7Abbott Vascular Inc. Company Overview 7Abbott Vascular Inc. Pipeline Products and Clinical Trials Overview 8Abbott Vascular Inc. Pipeline Analysis Overview 10Key Facts 10Abbott Vascular Inc. - Major Products and Services 11Abbott Vascular Inc. Pipeline Products by Development Stage 12Abbott Vascular Inc. Clinical Trials by Trial Status 14Abbott Vascular Inc. Pipeline Products Overview 18Absorb Bioresorbable Vascular Scaffold 18Absorb Bioresorbable Vascular Scaffold Product Overview 18Absorb Bioresorbable Vascular Scaffold Clinical Trial 19AVJ Everolimus Eluting Coronary Stent System 30AVJ Everolimus Eluting Coronary Stent System Product Overview 30Chemical RDN System 31Chemical RDN System Product Overview 31Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) 32Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) Product Overview 32ESPRIT Bioresorbable Vascular Scaffold 33ESPRIT Bioresorbable Vascular Scaffold Product Overview 33Mitral Valve Replacement Device 34Mitral Valve Replacement Device Product Overview 34Next Generation Mitral Regurgitation System 35Next Generation Mitral Regurgitation System Product Overview 35Next Generation SUPERA Delivery System 36Next Generation SUPERA Delivery System Product Overview 36Second Generation Bioresorbable Vascular Scaffold 37Second Generation Bioresorbable Vascular Scaffold Product Overview 37Xience SBA Everolimus Eluting Coronary Stent System 38Xience SBA Everolimus Eluting Coronary Stent System Product Overview 38XIENCE Thinman DES 39XIENCE Thinman DES Product Overview 39ZoMaxx Drug Eluting Coronary Stent System 40ZoMaxx Drug Eluting Coronary Stent System Product Overview 40Abbott Vascular Inc. - Key Competitors 41Abbott Vascular Inc. - Key Employees 42Abbott Vascular Inc. - Locations And Subsidiaries 43Head Office 43Recent Developments 44Abbott Vascular Inc., Recent Developments 44Mar 15, 2016: Abbott's Absorb, the First Fully Dissolving Heart Stent, Earns Positive Review by FDA Advisory Committee 44Feb 26, 2016: Abbott Issues Voluntary Safety Notice on MitraClip Delivery System Deployment Process 44Nov 03, 2015: Additional First Time Endovascular Clinical Trial Results Announced At VIVA15 45Oct 12, 2015: Abbott's One-year Trial Of Absorb Heart Stent Successful 46Sep 01, 2015: Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study 46Jul 20, 2015: John Muir Health Among First Hospitals in Northern California to Offer Breakthrough Device for Patients with Debilitating Heart Valve Disease 48May 19, 2015: Abbott Announces CE Mark For New Advancement Of Absorb Stent System For People With Heart Disease 48Mar 18, 2015: Cooper Heart Institute Participating in Study of New Heart Valve Treatment 49Mar 15, 2015: Abbott's MitraClip System Shown to Mend Hearts and Improve Lives in People in the United States 49Feb 02, 2015: ISET 2015: Minimally Invasive Clip Can Repair Mitral Valve Regurgitation 50Appendix 52Methodology 52About GlobalData 52Contact Us 52Disclaimer 52 5

6 List Of Tables in Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update List of Tables Abbott Vascular Inc. Pipeline Products and Clinical Trials Overview 9 Abbott Vascular Inc. Pipeline Products by Equipment Type 9 Abbott Vascular Inc. Pipeline Products by Indication 10 Abbott Vascular Inc. Clinical Trials by Trial Status 10 Abbott Vascular Inc., Key Facts 11 Abbott Vascular Inc., Major Products and Services 12 Abbott Vascular Inc. Number of Pipeline Products by Development Stage 13 Abbott Vascular Inc. Pipeline Products Summary by Development Stage 14 Abbott Vascular Inc. Clinical Trials by Trial Status 15 Abbott Vascular Inc. Clinical Trials Summary 16 Absorb Bioresorbable Vascular Scaffold - Product Status 19 Absorb Bioresorbable Vascular Scaffold - Product Description 19 Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Bioresorbable Vascular Scaffold, in the Treatment of Subjects with de Novo Native Coronary Artery Lesions in Chinese Population 20 Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold In the Treatment of Subjects with De Novo Native Coronary Artery Lesions 20 Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de Novo Native Coronary Artery Lesions 21 Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System (BVS EECSS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions 21 Absorb Bioresorbable Vascular Scaffold - A Clinical Evaluation to Compare the Safety, Efficacy and Performance of ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System Against XIENCE Everolimus Eluting Coronary Stent System in the Treatment of Subjects with Ischemic Heart Disease Caused by de Novo Native Coronary Artery Lesions: ABSORB II Randomized Controlled Trial 21 Absorb Bioresorbable Vascular Scaffold - A Continuation in the Clinical Evaluation of the Abbott Vascular Everolimus-Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de Novo Native Coronary Artery Lesions: ABSORB EXTEND Clinical Investigation 22 Absorb Bioresorbable Vascular Scaffold - A Multicenter Prospective Natural History Study Using Multimodality Imaging in Patients with Acute Coronary Syndromes - PROSPECT II (Natural History Study), Combined with a Randomized, Controlled, Intervention Study - PROSPECT ABSORB (Randomized Trial) 22 Absorb Bioresorbable Vascular Scaffold - A Post-market Registry of Patients with de Novo Lesions in Previously Untreated Vessels Treated with Absorb BVS 23 Absorb Bioresorbable Vascular Scaffold - A Prospective Evaluation of a Standardized Strategy for the Use of 6

7 Bioresorbable Vascular Scaffold in ST-segment Elevation Myocardial Infarction -The BVS STEMI STRATEGY-IT Registry 23 Absorb Bioresorbable Vascular Scaffold - A Prospective, Randomized Trial of Synergy Bioresorbable Polymer Coated Stents Versus Absorb Bioresorbable Backbone Stents in Patients Undergoing Coronary Stenting (ISAR- RESORB) 24 Absorb Bioresorbable Vascular Scaffold - A Randomized Controlled Comparison of Optical Coherence Tomography Guidance and Angiography-only Guidance for Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffold 24 Absorb Bioresorbable Vascular Scaffold - Absorb Bioresorbable Scaffold and Drug Coated Balloon for Treatment of In-Stent-Restenosis 25 Absorb Bioresorbable Vascular Scaffold - ABSORB Bioresorbable Scaffold versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis 25 Absorb Bioresorbable Vascular Scaffold - ABSORB III RCT Pharmacokinetics (PK) Sub-study 25 Absorb Bioresorbable Vascular Scaffold - Amsterdam Investigator-initiated Absorb Strategy All-comers Trial (AIDA Trial) - A Clinical Evaluation Comparing the Efficacy and Performance of ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold Strategy Versus the XIENCE Family (XIENCE PRIME or XIENCE Xpedition) Everolimus Eluting Coronary Stent Strategy in the Treatment of Coronary Lesions in Consecutive All-comers 26 Absorb Bioresorbable Vascular Scaffold - Comparison of a Paclitaxel-coated Balloon Without Stent Implantation Against an Everolimus-eluting Bioresorbable Scaffold for Treatment of Stable Coronary Artery Disease: A Prospective Randomized Study Using Optical Coherence Tomography 26 Absorb Bioresorbable Vascular Scaffold - Comparison of the ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System With a Drug- Eluting Metal Stent (Xience) in Acute ST-Elevation Myocardial Infarction 27 Absorb Bioresorbable Vascular Scaffold - Complex Bifurcation Lesions - A Randomized Comparison Between the AXXESS Device in Combination with Absorb BVS, and Modified T Stenting with Absorb BVS: An OCT Study 27 Absorb Bioresorbable Vascular Scaffold - Comprehensive Imaging and Interventional Therapy Studies for Arteriogenic Erectile Dysfunction and Lower Urinary Tract Symptoms: a Multi-modality, Multi-specialty Collaborative Study (PERFECT Program) 28 Absorb Bioresorbable Vascular Scaffold - Everolimus-eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients: A Prospective Multicenter Pilot Study 28 Absorb Bioresorbable Vascular Scaffold - German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-Eluting Bioresorbable Vascular Scaffold System in Patients with Coronary Artery Stenosis 29 Absorb Bioresorbable Vascular Scaffold - Impact of Vascular Reparative Therapy on Vasomotor Function and Myocardial Perfusion: A Randomized H215O PET/CT Study 29 Absorb Bioresorbable Vascular Scaffold - Optimal Lesion Preparation with Non-compliant Balloons for the Implantation of Bioresorbable Vascular Scaffolds (BVS) -OPRENBIS Study 29 Absorb Bioresorbable Vascular Scaffold - Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct (BVS in STEMI) 30 Absorb Bioresorbable Vascular Scaffold - Real World Advanced Experience of Bioresorbable Scaffold by Smart Angioplasty Research Team (SMART REWARD) 30 Absorb Bioresorbable Vascular Scaffold - Safety and Feasibility of Bioabsorbable Everolimus-Eluting Stents for Patients with Internal Pudendal Artery-related Arteriogenic Erectile Dysfunction (PERFECT-ABSORB) 30 7

8 AVJ Everolimus Eluting Coronary Stent System - Product Status 31 AVJ Everolimus Eluting Coronary Stent System - Product Description 31 Chemical RDN System - Product Status 32 Chemical RDN System - Product Description 32 Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Status 33 Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) - Product Description 33 ESPRIT Bioresorbable Vascular Scaffold - Product Status 34 ESPRIT Bioresorbable Vascular Scaffold - Product Description 34 Mitral Valve Replacement Device - Product Status 35 Mitral Valve Replacement Device - Product Description 35 Next Generation Mitral Regurgitation System - Product Status 36 Next Generation Mitral Regurgitation System - Product Description 36 Next Generation SUPERA Delivery System - Product Status 37 Next Generation SUPERA Delivery System - Product Description 37 Second Generation Bioresorbable Vascular Scaffold - Product Status 38 Second Generation Bioresorbable Vascular Scaffold - Product Description 38 Xience SBA Everolimus Eluting Coronary Stent System - Product Status 39 Xience SBA Everolimus Eluting Coronary Stent System - Product Description 39 XIENCE Thinman DES - Product Status 40 XIENCE Thinman DES - Product Description 40 ZoMaxx Drug Eluting Coronary Stent System - Product Status 41 ZoMaxx Drug Eluting Coronary Stent System - Product Description 41 Abbott Vascular Inc., Key Employees 43 8

9 List Of Figures, Charts and Diagrams in Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update List of Figures Abbott Vascular Inc. Pipeline Products by Equipment Type 10 Abbott Vascular Inc. Pipeline Products by Development Stage 13 Abbott Vascular Inc. Clinical Trials by Trial Status 15 9

10 How to Buy... Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $750 Single User Price $1500 Site License Price $2250 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 10